3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Triple Negative Breast Neoplasms
1
Radiation Injuries
1
Interventions
Cyclophosphamide
1492
Cisplatin
1415
Paclitaxel
1319
Radiotherapy
1261
Carboplatin
1250
Gemcitabine
1215
Docetaxel
1111
Bevacizumab
1031
Fluorouracil
895
Doxorubicin
792
Dexamethasone
748
Rituximab
720
Capecitabine
717
Oxaliplatin
701
pembrolizumab
680
Etoposide
678
Irinotecan
636
Filgrastim
621
Cytarabine
586
Leucovorin
579
Nivolumab
560
Vincristine
515
Prednisone
475
Cetuximab
465
Bortezomib
459
Erlotinib Hydrochloride
456
Trastuzumab
447
Methotrexate
438
Lenalidomide
428
Pemetrexed
420
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Interventional
×
Adenosine Diphosphate
×
Clear all
NCT03109080
2025-11-24
RadioPARP
Institut Curie
Phase 1
Completed
24 enrolled